Bilcare Ltd
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
- Market Cap ₹ 186 Cr.
- Current Price ₹ 79.1
- High / Low ₹ 98.0 / 51.0
- Stock P/E 46.7
- Book Value ₹ 178
- Dividend Yield 0.00 %
- ROCE 2.17 %
- ROE 0.96 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.44 times its book value
- Debtor days have improved from 143 to 82.3 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -41.0% over past five years.
- Promoter holding is low: 30.0%
- Company has a low return on equity of -1.48% over last 3 years.
- Contingent liabilities of Rs.709 Cr.
- Earnings include an other income of Rs.17.8 Cr.
- Company's cost of borrowing seems high
- Working capital days have increased from 679 days to 1,536 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
401.35 | 331.33 | 315.42 | 285.60 | 257.53 | 239.81 | 211.75 | 304.16 | 429.79 | 13.98 | 17.60 | 15.12 | |
336.96 | 310.30 | 300.30 | 288.45 | 257.77 | 238.89 | 219.34 | 279.00 | 393.05 | 21.12 | 26.71 | 20.80 | |
Operating Profit | 64.39 | 21.03 | 15.12 | -2.85 | -0.24 | 0.92 | -7.59 | 25.16 | 36.74 | -7.14 | -9.11 | -5.68 |
OPM % | 16.04% | 6.35% | 4.79% | -1.00% | -0.09% | 0.38% | -3.58% | 8.27% | 8.55% | -51.07% | -51.76% | -37.57% |
30.35 | 4.36 | -105.57 | 73.52 | 259.53 | 5.59 | 38.18 | 66.58 | 42.55 | 515.03 | 19.45 | 17.85 | |
Interest | 147.04 | 131.84 | 31.73 | 47.82 | 55.53 | 72.10 | 69.08 | 74.72 | 68.19 | 0.45 | 2.49 | 3.85 |
Depreciation | 67.81 | 105.52 | 101.29 | 79.23 | 304.34 | 248.47 | 88.06 | 34.63 | 34.64 | 4.52 | 2.15 | 2.87 |
Profit before tax | -120.11 | -211.97 | -223.47 | -56.38 | -100.58 | -314.06 | -126.55 | -17.61 | -23.54 | 502.92 | 5.70 | 5.45 |
Tax % | 1.12% | -13.35% | -65.00% | 16.94% | -20.52% | 0.38% | -19.15% | -110.11% | -24.47% | 22.30% | 6.32% | 26.79% |
-121.46 | -183.68 | -78.22 | -65.93 | -79.94 | -315.25 | -102.32 | 1.78 | -17.78 | 390.79 | 5.34 | 3.99 | |
EPS in Rs | -51.59 | -78.01 | -33.22 | -28.00 | -33.95 | -133.89 | -43.46 | 0.76 | -7.55 | 165.97 | 2.27 | 1.69 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -27% |
5 Years: | -41% |
3 Years: | -67% |
TTM: | -14% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | 28% |
TTM: | 137% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | 6% |
1 Year: | 32% |
Return on Equity | |
---|---|
10 Years: | -29% |
5 Years: | -10% |
3 Years: | -1% |
Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 |
Reserves | 831.24 | 643.47 | 598.97 | 532.92 | 453.08 | 137.88 | 35.63 | 37.17 | 19.86 | 386.86 | 392.11 | 396.13 |
1,227.93 | 1,151.44 | 975.70 | 898.21 | 856.59 | 867.63 | 708.56 | 678.41 | 689.92 | 7.52 | 10.29 | 10.82 | |
553.54 | 802.28 | 441.11 | 517.98 | 284.84 | 346.08 | 204.85 | 189.19 | 193.25 | 41.89 | 34.54 | 21.71 | |
Total Liabilities | 2,636.26 | 2,620.74 | 2,039.33 | 1,972.66 | 1,618.06 | 1,375.14 | 972.59 | 928.32 | 926.58 | 459.82 | 460.49 | 452.21 |
1,254.77 | 1,217.32 | 1,176.79 | 1,147.47 | 843.72 | 593.73 | 506.21 | 472.60 | 445.82 | 16.25 | 63.41 | 60.61 | |
CWIP | 181.61 | 124.66 | 0.00 | 0.00 | 0.25 | 0.28 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 683.13 | 682.43 | 552.73 | 552.88 | 514.03 | 513.37 | 173.17 | 89.49 | 80.51 | 293.51 | 293.52 | 293.52 |
516.75 | 596.33 | 309.81 | 272.31 | 260.06 | 267.76 | 293.21 | 366.15 | 400.25 | 150.06 | 103.56 | 98.08 | |
Total Assets | 2,636.26 | 2,620.74 | 2,039.33 | 1,972.66 | 1,618.06 | 1,375.14 | 972.59 | 928.32 | 926.58 | 459.82 | 460.49 | 452.21 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
177.21 | -16.68 | 28.44 | 37.28 | 7.17 | 62.13 | 71.12 | -0.41 | 46.29 | 397.43 | 97.63 | 2.34 | |
-31.09 | -14.39 | 8.62 | -48.08 | 78.31 | 1.51 | 10.82 | 85.02 | 5.59 | 180.97 | -107.06 | 2.95 | |
-153.00 | 22.55 | -35.07 | 6.24 | -86.70 | -60.25 | -83.03 | -82.28 | -55.47 | -570.94 | -0.51 | -3.84 | |
Net Cash Flow | -6.88 | -8.51 | 1.98 | -4.56 | -1.22 | 3.39 | -1.08 | 2.33 | -3.59 | 7.47 | -9.94 | 1.45 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 95.28 | 79.96 | 69.13 | 62.11 | 57.94 | 56.41 | 67.40 | 86.74 | 78.67 | 246.73 | 101.41 | 82.32 |
Inventory Days | 152.84 | 214.55 | 85.46 | 50.98 | 50.90 | 68.40 | 56.55 | 85.32 | 71.21 | 60.10 | 21.27 | 30.02 |
Days Payable | 165.49 | 180.64 | 77.49 | 86.11 | 114.26 | 155.62 | 128.77 | 116.24 | 100.16 | 439.03 | 91.35 | 154.06 |
Cash Conversion Cycle | 82.62 | 113.87 | 77.11 | 26.99 | -5.42 | -30.82 | -4.82 | 55.82 | 49.72 | -132.20 | 31.33 | -41.72 |
Working Capital Days | -12.29 | -104.94 | -225.39 | -320.99 | -75.32 | -162.55 | -98.37 | -0.18 | -4.43 | -638.36 | 1,138.76 | 1,536.28 |
ROCE % | -0.46% | -4.11% | -4.38% | -5.02% | -20.87% | -20.40% | -9.08% | 0.34% | 1.51% | -1.38% | -1.97% | 2.17% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Bilcare's revised secretarial compliance report for FY 2024-25 with minor filing delays, no major issues.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Bilcare's revised secretarial compliance report for FY2025 with minor filing delays, no major issues.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Bilcare's Annual Secretarial Compliance Report for FY 2024-25 with minor filing delays, no major non-compliance.
-
Integrated Filing (Financial)
29 May - Bilcare reports FY25 audited results; standalone profit turnaround; consolidated loss; 75 Cr asset sale; ongoing SFIO probe noted.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Products & Services offered:
a) Pharma Packaging:[1]
Pharma Packaging is available in two broad categories viz., Polymer based Packaging Films and Aluminum based Packaging Foils. Their sub-categories are:
Blister Films
Blister Foils
Lidding Foils
CR Foils
Laminates
b) Global Clinical Supplies and Services:[2]
Company handles domestic and global manufacturing of IMPs and Placebos, Primary
and secondary packaging with various blinding techniques, IWRS, Storage at variable temperatures.